VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection

M. R. Schleiss

Research output: Contribution to journal › Review article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds